COMMUNIQUÉS West-GlobeNewswire

DBV Technologies Appoints Daniel Tassé as Chief Executive Officer

16/11/2018 - 07:31

Montrouge, France, November 16, 2018 DBV Technologies Appoints Daniel Tassé as Chief Executive Officer Daniel brings strong track record of building and leading global organizations and delivering transformative [...]

DBV Technologies nomme Daniel Tassé au poste de Directeur Général

16/11/2018 - 07:31

Montrouge, France, le 16 novembre (07h30 CET), 2018 DBV Technologies nomme Daniel Tassé au poste de Directeur Général M. Tassé possède une solide expérience dans la direction de sociétés pharmaceutiques globales et dans [...]

TOMI Environmental Solutions, Inc. Announces Milestone With Record Revenue in the Third Quarter

16/11/2018 - 00:14

BEVERLY HILLS, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global provider of infection prevention and decontamination products, services and research, including [...]

Childhood Obesity Foundation applauds recommendation to apply PST to Sugary Drinks

15/11/2018 - 23:11

VANCOUVER, British Columbia, Nov. 15, 2018 (GLOBE NEWSWIRE) -- BC’s Select Standing Committee on Finance and Government Services’ report today recommends once again that PST be applied to sugary drinks. This is a step [...]

Mesoblast Reports First Quarter Ended September 30, 2018 Financial Results and Operational Highlights

15/11/2018 - 22:33

MELBOURNE, Australia and NEW YORK, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO) today reported strong financial results and provided operational highlights for the first quarter ended [...]

Viveve Named One of North America’s 500 Fastest Growing Companies by Deloitte

15/11/2018 - 22:28

Company awarded sixth place overall and is only medical device company listed in the top ten ENGLEWOOD, Colo., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused [...]

The Cooper Companies to Participate in the BMO Healthcare Conference

15/11/2018 - 22:15

PLEASANTON, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) will participate in the BMO Prescriptions for Success Healthcare Conference in New York, NY, on December 12, 2018. Brian G. [...]

Equillium Reports Third Quarter 2018 Financial Results and Recent Highlights

15/11/2018 - 22:07

Completes Successful Initial Public Offering Raising Gross Proceeds of Approximately $71.6 Million On-Track for Early 2019 Initiation of Phase 1b/2 Trial of EQ001 in Acute Graft-Versus-Host Disease LA JOLLA, Calif., Nov [...]

ERYTECH Partners with New York Blood Center for Red Blood Cell Supply and Research

15/11/2018 - 22:05

LYON, France and CAMBRIDGE, Mass., Nov. 15, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug [...]

ERYTECH s’associe au New York Blood Center pour l’approvisionnement et la recherche sur les globules rouges

15/11/2018 - 22:05

LYON, France et CAMBRIDGE, Mass., 15 nov. 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris : ERYP - Nasdaq : ERYP), société biopharmaceutique de stade clinique développant des thérapies innovantes par [...]

National Brain Tumor Society CEO Receives Inaugural Community Service Award at Society of Neuro-Oncology Annual Meeting

15/11/2018 - 20:18

Boston, MA, Nov. 15, 2018 (GLOBE NEWSWIRE) -- National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, today announced that its Chief Executive Officer, [...]

NeuroMetrix Announces DPNCheck Collaboration Agreement with Fukuda Denshi for Japan Market

15/11/2018 - 18:50

WALTHAM, Mass., Nov. 15, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), announced today that it had executed a distribution agreement with Fukuda Denshi Co. Ltd. for DPNCheck ® , the Company’s rapid, point-of [...]

CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social

15/11/2018 - 18:43

Communiqué de Presse Information relative au nombre total de droits de vote et d'actions composant le capital social Dijon, le 15 novembre 2018 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]

Information concerning the total number of voting rights and shares

15/11/2018 - 18:01

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l' [...]

Informations relatives au nombre total de droits de vote et d'actions

15/11/2018 - 18:01

Informations relatives au nombre total de droits de vote et d'actions prévues par l'article L. 233-8 II du Code de commerce et l'article 223-16 du Règlement général de l'Autorité des Marchés Financiers Sanofi Société [...]

Nanobiotix revenues for the 3rd quarter of 2018

15/11/2018 - 18:00

Paris, France and Cambridge, Massachusetts, USA, November 15, 2018 – NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, [...]

Nanobiotix : Chiffre d’affaires du troisième trimestre 2018

15/11/2018 - 18:00

Chiffre d’affaires du troisième trimestre 2018 Paris, France, et Cambridge, Massachusetts (USA) le 15 novembre 2018 – NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205 – la « Société »), société française pionnière en [...]

SPINEWAY :Spineway sets up the governing structure for its US subsidiary

15/11/2018 - 17:46

Press release Ecully, 15 November 2018 Spineway sets up the governing structure for its US subsidiary Appointment of Jon Luedke as CEO Spineway, specialist in surgical implants and instruments for treating disorders of [...]

SPINEWAY :Spineway structure la gouvernance de sa filiale US

15/11/2018 - 17:46

Communiqué de presse Ecully, le 15 novembre 2018 Spineway structure la gouvernance de sa filiale US Nomination de Jon Luedke au poste de CEO Spineway, spécialiste des implants et ancillaires chirurgicaux pour le [...]